Date: February 5, 2016
ROC President Ma Ying-jeou said Feb. 4 that the government is
ramping up efforts to develop Taiwan’s biotechnology and medical care sectors, eyeing NT$4 trillion (US$120.4 billion) in total production by 2025.
“Biotechnology is set to become a major growth engine for the local economy in the years ahead, building on Bio Taiwan Committee’s comprehensive promotion plan spanning areas like agriculture, food, health care, medical instruments and pharmaceuticals,” Ma said.
“Capitalizing on cross-sector integration provided by such initiatives as the Taiwan Biotechnology Take-off Diamond Action Plan, our biomedicine revenue topped NT$280 billion in 2014, along with 94 public listed companies by the end of last year. [FULL STORY]